ICOSLG and pulmonary arterial hypertension: Indeed, the main finding of our study is the observation that the soluble ICOS and ICOSL are both increased in patients with pulmonary arterial hypertension; it is particularly interesting that this finding is not dependent on the underlying cause of PAH.